Mylan to merge with Pfizer’s Upjohn
Pfizer will combine its off-patent drug business with Mylan. Pfizer shareholders would own 57% of the new company and Mylan’s shareholders would get 43%. The combined company, which will sell Mylan’s EpiPen and Pfizer’s Viagra, will be domiciled in the...